The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111271632 11127163 2 F 2007 20160425 20150521 20160822 PER US-ASTRAZENECA-2007BM20167 ASTRAZENECA 62.00 YR F Y 0.00000 20160822 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111271632 11127163 1 PS BYETTA EXENATIDE 1 Subcutaneous 21773 5 UG INJECTION BID
111271632 11127163 2 SS BYETTA EXENATIDE 1 Subcutaneous A310425 21773 10 UG INJECTION BID
111271632 11127163 3 SS BYETTA EXENATIDE 1 Subcutaneous 5.0UG UNKNOWN 21773 5 UG INJECTION
111271632 11127163 4 SS BYETTA EXENATIDE 1 Subcutaneous 10.0UG UNKNOWN 21773 10 UG INJECTION
111271632 11127163 5 SS BYDUREON EXENATIDE 1 Subcutaneous U U FA0149 0 2 MG INJECTION /wk
111271632 11127163 6 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral U U 0 40 MG CAPSULE QD
111271632 11127163 7 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral U U 0 40 MG CAPSULE QD
111271632 11127163 8 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 40.0MG UNKNOWN U 0 40 MG
111271632 11127163 9 C ANAGRELIDE HYDROCHLORIDE. ANAGRELIDE HYDROCHLORIDE 1 UNK 0
111271632 11127163 10 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 0 .08 UG QD
111271632 11127163 11 C LIPITOR ATORVASTATIN CALCIUM 1 Oral 0 40 MG QD
111271632 11127163 12 C NEURONTIN GABAPENTIN 1 UNK 0
111271632 11127163 13 C LIBRAX CHLORDIAZEPOXIDE HYDROCHLORIDECLIDINIUM BROMIDE 1 UNK 0
111271632 11127163 14 C MONOPRIL FOSINOPRIL SODIUM 1 Oral 10 MG, QD 0 10 MG TABLET QD
111271632 11127163 15 C DYAZIDE HYDROCHLOROTHIAZIDETRIAMTERENE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111271632 11127163 1 Type 2 diabetes mellitus
111271632 11127163 2 Type 2 diabetes mellitus
111271632 11127163 3 Type 2 diabetes mellitus
111271632 11127163 4 Type 2 diabetes mellitus
111271632 11127163 5 Type 2 diabetes mellitus
111271632 11127163 6 Hiatus hernia
111271632 11127163 7 Gastrooesophageal reflux disease
111271632 11127163 9 Platelet count increased
111271632 11127163 10 Type 2 diabetes mellitus
111271632 11127163 12 Neuropathy peripheral
111271632 11127163 14 Blood pressure increased
111271632 11127163 15 Blood pressure increased

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
111271632 11127163 Blood glucose decreased
111271632 11127163 Blood glucose increased
111271632 11127163 Feeling cold
111271632 11127163 Injection site mass
111271632 11127163 Off label use
111271632 11127163 Product use issue
111271632 11127163 Pruritus

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111271632 11127163 1 200701 200702 0
111271632 11127163 2 200702 0
111271632 11127163 5 20150411 0